| EX-10.14 - SUBLEASE AGREEMENT, DATED JULY 29, 2016. - Compass Therapeutics, Inc. | ea123278ex10-14_compass.htm |
| EX-99.4 - PRESS RELEASE DATED JUNE 23, 2020 - Compass Therapeutics, Inc. | ea123278ex99-4_compass.htm |
| EX-99.3 - UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS AS OF AND FOR THE FISCAL YEAR - Compass Therapeutics, Inc. | ea123278ex99-3_compass.htm |
| EX-99.2 - UNAUDITED FINANCIAL STATEMENTS OF COMPASS THERAPEUTICS, LLC AS OF AND FOR THE QU - Compass Therapeutics, Inc. | ea123278ex99-2_compass.htm |
| EX-99.1 - AUDITED FINANCIAL STATEMENTS OF COMPASS THERAPEUTICS, LLC AS OF AND FOR THE FISC - Compass Therapeutics, Inc. | ea123278ex99-1_compass.htm |
| EX-16.1 - LETTER FROM RAICH ENDE MALTER & CO. LLP - Compass Therapeutics, Inc. | ea123278ex16-1_compass.htm |
| EX-10.15 - SUBLEASE MODIFICATION AGREEMENT, DATED JANUARY 17, 2018. - Compass Therapeutics, Inc. | ea123278ex10-15_compass.htm |
| EX-10.13 - THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT, DATED OCTOBER 29, 2019. - Compass Therapeutics, Inc. | ea123278ex10-13_compass.htm |
| EX-10.12 - SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT, DATED MARCH 8, 2019. - Compass Therapeutics, Inc. | ea123278ex10-12_compass.htm |
| EX-10.11 - FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT, DATED SEPTEMBER 26, 2018. - Compass Therapeutics, Inc. | ea123278ex10-11_compass.htm |
| EX-10.10 - LOAN AND SECURITY AGREEMENT, DATED MARCH 30, 2018. - Compass Therapeutics, Inc. | ea123278ex10-10_compass.htm |
| EX-10.9 - AMENDED AND RESTATED COLLABORATION AGREEMENT, DATED FEBRUARY 11, 2015. - Compass Therapeutics, Inc. | ea123278ex10-9_compass.htm |
| EX-10.8 - SUBSCRIPTION AGREEMENT, DATED JUNE 19, 2020. - Compass Therapeutics, Inc. | ea123278ex10-8_compass.htm |
| EX-10.7 - REGISTRATION RIGHTS AGREEMENT, DATED JUNE 19, 2020. - Compass Therapeutics, Inc. | ea123278ex10-7_compass.htm |
| EX-10.6 - FORM OF PRE-MERGER INDEMNIFICATION AGREEMENT (DIRECTORS AND EXECUTIVE OFFICERS) - Compass Therapeutics, Inc. | ea123278ex10-6_compass.htm |
| EX-10.5 - FORM OF INDEMNIFICATION AGREEMENT (EXECUTIVE OFFICERS) - Compass Therapeutics, Inc. | ea123278ex10-5_compass.htm |
| EX-10.4 - FORM OF INDEMNIFICATION AGREEMENT (DIRECTORS) - Compass Therapeutics, Inc. | ea123278ex10-4_compass.htm |
| EX-10.3 - OFFER LETTER, DATED NOVEMBER 8, 2017, BETWEEN VERED BISKER-LEIB AND COMPASS THER - Compass Therapeutics, Inc. | ea123278ex10-3_compass.htm |
| EX-10.2 - 2020 SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN - Compass Therapeutics, Inc. | ea123278ex10-2_compass.htm |
| EX-10.1 - 2020 STOCK OPTION AND INCENTIVE PLAN - Compass Therapeutics, Inc. | ea123278ex10-1_compass.htm |
| EX-3.3 - AMENDED AND RESTATED BYLAWS - Compass Therapeutics, Inc. | ea123278ex3-3_compass.htm |
| EX-3.2 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Compass Therapeutics, Inc. | ea123278ex3-2_compass.htm |
| EX-3.1 - CERTIFICATE OF MERGER - Compass Therapeutics, Inc. | ea123278ex3-1_compass.htm |
| EX-2.1 - AGREEMENT AND PLAN OF MERGER, DATED JUNE 17, 2020. - Compass Therapeutics, Inc. | ea123278ex2-1_compass.htm |
| 8-K - CURRENT REPORT - Compass Therapeutics, Inc. | ea123278-8k_compasstherap.htm |
